Apoptotic, Regenerative, And Immune-Related Signaling in Human Islets from Type 2 Diabetes Individuals
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Islet dysfunction is a primary cause of developing type 2 diabetes mellitus (T2DM). Events leading to islet failure are still poorly defined due to the complexity of the disease and scarcity of human T2DM islets. The aim of the present study was to identify cellular mechanisms involved in the T2DM pathophysiology by protein profiling islets obtained from T2DM individuals and age- and weight-matched controls using liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry and surface enhanced laser desorption/ionization time-of-flight mass spectrometry. In T2DM islets, multiple differentially expressed proteins correlated with insulin secretion. When these T2DM islet proteins were analyzed for differential pathway activation, three of the five most activated pathways were pathways of cell arrest and apoptosis (p53, caspase, stress-activated), one represented immune-response (Fas), and the most activated pathway was connected with proliferation and regeneration (E2F). Among the inactivated pathways, three out of five were pathways of proliferation and regeneration (insulin, PRL, PDGF). The present study is the first to report differential activation of specific pathways during T2DM islet deterioration. The information about alterations in pathway signaling patterns may open new ways to develop strategies aimed at restoring islet cell function and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior studies correlated increased PDGFR and EZH2 expression in human endocrine neoplasias38, and disrupted PDGF signalling in β-cells of humans with type 2 diabetes39.”
From PDGF signalling controls age-dependent proliferation in pancreatic β-cells (2011) · cites this paper as [39]
Citations
Cites
1 retracted
Maedler, K., Schumann, D. M., Sauter, N., Ellingsgaard, H., Bosco, D., Baertschiger, R., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 156
Retractedβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Schulze, M. B. (2004) · JAMA · doi:10.1001/jama.292.8.927 · Cited by 1,639
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510790103 · Cited by 1,312
Kulkarni, R. N., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612
Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
Del Guerra, S., Lupi, R., Marselli, L., Masini, M., Bugliani, M., Sbrana, S., Torri, S., Pollera, M., Boggi, U., Mosca, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.727 · Cited by 466
Self-citation
Cited by
Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.019 · Cited by 489
“For instance, quantitative protein profiling of islets from T2D and non-diabetic individuals revealed differential expression in twenty major pathways, which correlated with their insulin secretion profile [151].”
BackgroundToperoff, G., Aran, D., Kark, J. D., Rosenberg, M., Dubnikov, T., Nissan, B., Wainstein, J., Friedlander, Y., Levy-Lahad, E., Glaser, B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr472 · Cited by 349
“Similar to USF1/2, MYCN and E2F family members bind their target sequences in a methylation-dependent manner (30,31), and might participate in T2DM-related pathways (32).”
BackgroundPDGF signalling controls age-dependent proliferation in pancreatic β-cells
Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S. E., Bottino, R., Schorle, H., Sage, J., & Kim, S. K. (2011) · Nature · doi:10.1038/nature10502 · Cited by 278
Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Schyr-Ben Haroush, R., Hija, A., Stolovich-Rain, M., Furth-Lavi, J., Granot, Z., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.007 · Cited by 141
“Analysis of islets from T2D patients previously identified an increased expression of proteins in the p53 pathway (Nyblom et al., 2009) and increased mRNA expression of the p53 target p21 (Marselli et al.”
BackgroundFong, T. T., Lok, C., Chung, C. Y., Fung, Y. M. E., Chow, P., Wan, P., & Che, C. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602814 · Cited by 139
Telomerase deficiency impairs glucose metabolism and insulin secretion
Kuhlow, D., Florian, S., von Figura, G., Weimer, S., Schulz, N., Petzke, K. J., Zarse, K., Pfeiffer, A. F. H., Rudolph, K. L., & Ristow, M. (2010) · Aging · doi:10.18632/aging.100200 · Cited by 130
“Moreover, several of the known downstream targets of telomerase have been identified to affect islet cell growth and regeneration [29,30], whereas a link to telomerase deficiency had not been established.”
BackgroundPostolache, T. T., del Bosque‐Plata, L., Jabbour, S. A., Vergare, M. J., Wu, R., & Gragnoli, C. (2019) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32712 · Cited by 119
“2001), islet proliferation (Nyblom et al., 2009), insulin secretion and”
BackgroundMechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Mizuki, Y., Sakamoto, S., Okahisa, Y., Yada, Y., Hashimoto, N., Takaki, M., & Yamada, N. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa097 · Cited by 93
“, 2001), islet regeneration and proliferation (Nyblom et al., 2009), and insulin secretion (Sorenson and Brelje, 2009).”
BackgroundSurvival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway
Zhou, Y., Zhang, E., Berggreen, C., Jing, X., Osmark, P., Lang, S., Cilio, C., Göransson, O., Groop, L., Renström, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr454 · Cited by 59
“In fact, the most activated was the E2F pathway, followed by the p53 pathway (33).”
BackgroundThe Pancreatic β Cells in Human Type 2 Diabetes
Marchetti, P., Bugliani, M., Boggi, U., Masini, M., & Marselli, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_22 · Cited by 68
Self-citationThe influence of the telomere-telomerase system on diabetes mellitus and its vascular complications
Nan, W. Q., Ling, Z., & Bing, C. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1016500 · Cited by 47
Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues
Diamanti, K., Cavalli, M., Pereira, M. J., Pan, G., Castillejo-López, C., Kumar, C., Mundt, F., Komorowski, J., Deshmukh, A. S., Mann, M., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100763 · Cited by 45
“39–41 The most interesting group in the PD network was the upregulation of biological processes involved in the regulation of the immune response in pancreatic islets and liver (Figures 2A and 5A).”
Krol, S., Ellis-Behnke, R. G., & Marchetti, P. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.12.004 · Cited by 36
Self-citationGalazis, N., Afxentiou, T., Xenophontos, M., Diamanti‐Kandarakis, E., & Atiomo, W. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0718 · Cited by 31
Fukumoto, R., & Kiang, J. G. (2011) · Radiation Research · doi:10.1667/rr2534.1 · Cited by 26
“Aberrant expression of or mutation in TP53 has also been observed in many cancer onsets and progressions (34), metabolic disorders (35) and DNA damage responses (36).”
BackgroundKrol, S., Ellis-Behnke, R. G., & Marchetti, P. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.005 · Cited by 28
Self-citationLoss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response
Gorrepati, K. D. D., Lupše, B., Annamalai, K., Yuan, T., Maedler, K., & Ardestani, A. D. (2018) · iScience · doi:10.1016/j.isci.2018.02.003 · Cited by 22
“…in human and rodent diabetic islets/b-cells in vitro and in vivo and correlate with b-cell death (Belgardt et al., 2015; Himpe et al., 2016; Nyblom et al., 2009; Oleson et al., 2014, 2016; Tornovsky-Babeay et al., 2014), we sought to determine whether USP1 inhibition would modulate DDR…”
BackgroundResultHatanaka, M., Anderson‐Baucum, E. K., Lakhter, A. J., Kono, T., Maier, B., Tersey, S. A., Tanizawa, Y., Evans‐Molina, C., Mirmira, R. G., & Sims, E. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-03869-5 · Cited by 20
Song, Y., He, C., Jiang, Y., Yang, M., Zhao, X., Yuan, L., Zhang, W., & Xu, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1132194 · Cited by 17
“The E2F signaling pathway is associated with the proliferation and regeneration of islets from patients with T2D (113).”
BackgroundFong, T. T., Lok, C., Chung, C. Y., Fung, Y. M. E., Chow, P., Wan, P., & Che, C. (2016) · Angewandte Chemie · doi:10.1002/ange.201602814 · Cited by 13
Unraveling pancreatic islet biology by quantitative proteomics
Zhou, J.-Y., Dann, G. P., Liew, C. W., Smith, R. D., Kulkarni, R., & Qian, W. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.39 · Cited by 13
Kang, C., Yu, H., & Yi, G. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-s1-s3 · Cited by 12
“The platelet-derived growth factor (PDGF) signaling pathway, which controls islet regeneration and proliferation, is inactivated in T2D cases [44].”
BackgroundCarey, C., Purohit, S. B., & She, J. (2010) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2010.508492 · Cited by 11
β‐Cell mass and function in human type 2 diabetes
Marchetti, P., & Ferrannini, E. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch24 · Cited by 12
Self-citationBarzalobre-Geronimo, R., Contreras‐Ramos, A., Cervantes-Cruz, A. I., Cruz, M., Suárez‐Sánchez, F., Gómez-Zamudio, J. H., Díaz-Rosas, G., Ávalos‐Rodríguez, A., Díaz-Flores, M., & Ortega‐Camarillo, C. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01147-y · Cited by 6
Membrane Protein Profiling of Human Islets of Langerhans Using Several Extraction Methods
Hansson, S., Henriksson, Å., Johansson, L., Korsgren, O., Eriksson, J. W., Tornqvist, H. E., & Davidsson, P. (2010) · Clinical Proteomics · doi:10.1007/s12014-010-9060-1 · Cited by 7
“been indicated that the progression of islet destruction in type 2 diabetes islets may be the result of specific changes in pathway activation of signaling related to proliferation and regeneration [36].”
BackgroundAl-Baqeri, A., Al‐Habori, M., Al-Eryani, E., & Saif-Ali, R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01969-1 · Cited by 4
“Analysis of islets from T2DM patients revealed upregulation of multiple p53-pathway proteins [44].”
Börjesson, A., Rønn, S. G., Karlsen, A. E., Billestrup, N., & Sandler, S. (2011) · Immunology Letters · doi:10.1016/j.imlet.2010.12.007 · Cited by 4
Hu, H., Shao, D., Wang, L., He, F., Huang, X., Lu, Y., Xiang, X., Zhu, S., Zhang, P., Li, J., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10653 · Cited by 5
“a number of studies have shown that cell cycle regulating factors are pivotal in β-cell function, proliferation and apoptosis (3,4).”
BackgroundKang, C., Yu, H., & Yi, G. (2012) · Data and Text Mining in Bioinformatics · doi:10.1145/2390068.2390070 · Cited by 2
“The platelet-derived growth factor (PDGF) signaling pathway, which controls islet regeneration and proliferation, is inactivated in T2D cases [41].”
BackgroundMechanisms Of Pancreatic Beta Cell Dysfunction In Diabetes
Sidarala, V. (2016) · Human Biology · Cited by 1
Protein expression analysis of Insulin producing cells exposed to endoplasmic reticulum stress
Rosengren, V. (2015) · Figshare · Cited by 1
Metadata
- Authors
- Nyblom, H. K., Bugliani, M., Fung, E., Boggi, U., Zubarev, R., Marchetti, P., & Bergsten, P.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Zubarev, Roman
- Bergsten, Peter
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 5650-5656
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2003385277
- Cited by
- 33
- References
- 49
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 3 · 2013: 3 · 2012: 4
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Proteome Research (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 2 diabetes, pancreatic islets, islet dysfunction, apoptosis, cell cycle arrest, islet regeneration, immune signaling, p53, caspases, Fas, E2F transcription factors, insulin secretion, proteomic profiling, pathway activation
- MeSH terms
- Insulin Secretion, Aged, Diabetes Mellitus, Type 2, Female, Gene Expression Regulation, Humans, Immunity, Insulin, Islets of Langerhans, Male, Middle Aged, Proteins, Regeneration, Signal Transduction, Case-Control Studies, Apoptosis, Proteomics, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.